Back

Impact of age on patient selection in leadless pacemaker implant: experience with the micra transcatheter pacemaker

8 April 2024 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session on devices, others Antibradycardia Pacing EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Saverio Iacopino

Maria Cecilia Hospital, Cotignola (Italy)

108 More presentations in this session

Presentation thumbnail
Emergency leadless pacing implantation is feasible and safe out-of-hours
Doctor F. O'Rourke (London, GB)
Abstract Slides Video
Presentation thumbnail
Outcomes of subcutaneous implantable cardioverter defibrillators: UK tertiary centre experience
Doctor L. Toon (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of the quality of life of patients with leadless pacing system during 1 year follow-up period
Doctor A. Baimbetov (Almaty, KZ)
Abstract Slides
Presentation thumbnail
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?
Mr C. Israel (Bielefeld, DE)
Abstract Slides Video
Presentation thumbnail
Procedural heart rate variability and its effect on short-term symptoms after cardioneuromodulation procedure
Doctor S. AYGUN (Ankara, TR)
Abstract

Access the full session

Session thumbnail
Poster session on devices, others

The Event

Event poster

EHRA 2024

8 April 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Eight year Follow-Up Data on a Leadless Pacing System Real life experience in comparison to data of the prospective trial
30 August 2024
thumbnail
Congress Presentation
Prognostic factors and outcomes in patients under 75 years old receiving transcatheter aortic valve implantation: insights from the LAPLACE registry
30 August 2025
thumbnail
Congress Presentation
Young adults receiving permanent pacemakers
18 May 2025
thumbnail
Congress Presentation
Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources